As an oncogene, lnc‐ANRIL has been extensively studied in many diseases like hepatocellular carcinoma, gastric cancer, prostate cancer, and diabetes mellitus.20, 21, 22, 23. The gene discussed is CDKN2B-AS1; the disease is hepatocellular carcinoma.